Disease State Theater An Interactive Educational Experience Trademark Details

Disease State Theater an Interactive Educational Experience was registered on Tuesday, April 7, 2009 and is currently owned by Cognimed Inc. under the registration number 3601615 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, November 13, 2015, according to the United State Patent & Trademark Office
Word Mark Disease State Theater an Interactive Educational Experience
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Cognimed Inc. of Livingston, NJ

View all trademarks for Cognimed Inc.
Other Trademarks for Cognimed Inc.
Serial Number 77526047
Registration Number 3601615
Status Date Friday, November 13, 2015
Filing Date Friday, November 13, 2015
Registration Date Tuesday, April 7, 2009
Attorney Thomas L. Adams

Correspondent

THOMAS L. ADAMS
LAW OFFICE OF THOMAS L. ADAMS
120 EAGLE ROCK AVE STE 130
EAST HANOVER, NJ 07936-3159

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Disease State Theater an Interactive Educational Experience"
Description of Mark The mark consists of figures representing people in front of a movie screen with the words "Disease State Theater an interactive educational experience" below.
Goods & Services Educational services, namely, live healthcare educational interactive presentations for health care providers

Classifications

International Class Codes
041 — Class 41 covers mainly services rendered by persons or institutions in the development of the mental faculties of persons or animals, as well as services intended to entertain or to engage the attention.
U.S. Class Codes 100, 101, 107
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 13, 2015
First Use Anywhere Friday, May 16, 2008
First Use In Commerce Friday, May 16, 2008
Primary Code 041

You must be signed in to print.

Once signed in, look for the PDF button.